Alnylam Canada ULC

Alnylam is a leading US based RNAi therapeutics company operating around the world. Founded in 2002 with a vision to turn Nobel Prize-winning science into a new class of medicines, we have worked tirelessly  to turn the scientific possibility of RNAi into reality. We believe that our efforts have the potential to improve the lives of patients who are waiting for treatment.